Physician profile
Christopher Scuderi
NPI 1760454037
$2,443.05
in general payments reported to CMS, 2019-2025
18 companies · $515 in 2025
The $515 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $49.08 · 2022: $256 · 2023: $1,308 · 2024: $315 · 2025: $515.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,138.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,137.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $906.87 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Novo Nordisk INC | $543.43 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Astellas Pharma US INC | $169.87 | 2024-2025 | Veozah |
| Painteq LLC | $150.00 | 2024 | Painteq |
| Abiomed | $128.95 | 2022 | |
| Abbvie INC. | $114.52 | 2022-2023 | Vraylar, Qulipta, Ubrelvy |
| Dexcom, INC. | $90.00 | 2025 | Dexcom G6 Transmitter |
| Boston Scientific Corporation | $53.86 | 2023-2024 | Bionic Navigator |
| Irhythm Technologies, INC. | $50.60 | 2022-2023 | Zio Xt Patch |
| Bayer Healthcare Pharmaceuticals INC. | $48.12 | 2023-2025 | |
| Amgen INC. | $41.96 | 2019 | |
| Novartis Pharmaceuticals Corporation | $31.11 | 2022-2023 | |
| Philips North America LLC | $31.01 | 2024 | (Ck7) Extended Holter |
| Pfizer INC. | $23.60 | 2025 | |
| Horizon Therapeutics Plc | $20.08 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $16.92 | 2025 | Cologuard Collection Kit |
| Glaxosmithkline, LLC. | $15.03 | 2023 | Shingrix |
| Takeda Pharmaceuticals U.S.A., INC. | $7.12 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Scuderi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.